Friberg Gregory R

EVP, Chief R&D Officer at BIOMARIN PHARMACEUTICAL INC · on record since May 11, 2026

Insider trading activity of Friberg Gregory R

Transactions on record: 13; since Oct 1, 2024

Open-market buys: 0

Open-market sells: 2; $558.6K

Companies traded: 1; last filing Oct 1, 2026

Figures computed from official regulatory filings — .

Companies where Friberg Gregory R has traded

BIOMARIN PHARMACEUTICAL INC13 tx · $1.1M · Oct 1, 2026

Track record of Friberg Gregory R

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Friberg Gregory R

Co-insiders of Friberg Gregory R

Acosta AndreaBIOMARIN PHARMACEUTICAL INC
Ajer Jeffrey RobertBIOMARIN PHARMACEUTICAL INC
Alles Mark JBIOMARIN PHARMACEUTICAL INC
ANDERSON ELIZABETH MBIOMARIN PHARMACEUTICAL INC
ASELAGE STEVEBIOMARIN PHARMACEUTICAL INC
BAFFI ROBERTBIOMARIN PHARMACEUTICAL INC
BATE KENNETHBIOMARIN PHARMACEUTICAL INC
BIENAIME JEAN JACQUESBIOMARIN PHARMACEUTICAL INC
Bodem Barbara W.BIOMARIN PHARMACEUTICAL INC
Burkhart ErinBIOMARIN PHARMACEUTICAL INC
CLARK IAN TBIOMARIN PHARMACEUTICAL INC
Cooper Jeffrey HBIOMARIN PHARMACEUTICAL INC
Countouriotis AthenaBIOMARIN PHARMACEUTICAL INC
CRISTIANI FRANZ LBIOMARIN PHARMACEUTICAL INC
Davis George EricBIOMARIN PHARMACEUTICAL INC
Dere Willard HBIOMARIN PHARMACEUTICAL INC
DRAPEAU LOUISBIOMARIN PHARMACEUTICAL INC
Enyedy Mark JBIOMARIN PHARMACEUTICAL INC
FALBERG KATHRYN EBIOMARIN PHARMACEUTICAL INC
FUCHS HENRY JBIOMARIN PHARMACEUTICAL INC
GREY MICHAEL GBIOMARIN PHARMACEUTICAL INC
Guyer Charles GregBIOMARIN PHARMACEUTICAL INC
Hardy AlexanderBIOMARIN PHARMACEUTICAL INC
HERON ELAINE JBIOMARIN PHARMACEUTICAL INC
Ho MaykinBIOMARIN PHARMACEUTICAL INC
HOMBACH ROBERT J.BIOMARIN PHARMACEUTICAL INC
Hubbard CristinBIOMARIN PHARMACEUTICAL INC
KAKKIS EMIL DBIOMARIN PHARMACEUTICAL INC
KLEIN JOSEPH IIIBIOMARIN PHARMACEUTICAL INC
LANDAU JEFFREYBIOMARIN PHARMACEUTICAL INC
LAPALME PIERREBIOMARIN PHARMACEUTICAL INC
LAWLIS V BRYANBIOMARIN PHARMACEUTICAL INC

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2026	Other	-4,086	60.00 USD	$245.2K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 11, 2026	Sell	-3,281	53.85 USD	$176.7K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2026	Other	-1,629	56.05 USD	$91.3K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2026	Award	19,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2026	AwardD (derivative)	45,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Feb 26, 2026	Sell	-6,326	60.38 USD	$382K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Feb 13, 2026	Award	398	45.54 USD	$18.1K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 2, 2025	Other	-3,304	54.16 USD	$178.9K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2025	AwardD (derivative)	41,170	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2025	Award	17,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2024	AwardD (derivative)	49,850	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2024	Award	21,190	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2024	Award	7,870	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2026	Other	-4,086	60.00 USD	$245.2K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	May 11, 2026	Sell	-3,281	53.85 USD	$176.7K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2026	Other	-1,629	56.05 USD	$91.3K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2026	Award	19,150	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2026	AwardD (derivative)	45,600	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Feb 26, 2026	Sell	-6,326	60.38 USD	$382K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Feb 13, 2026	Award	398	45.54 USD	$18.1K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 2, 2025	Other	-3,304	54.16 USD	$178.9K	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2025	AwardD (derivative)	41,170	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Mar 18, 2025	Award	17,750	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2024	AwardD (derivative)	49,850	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2024	Award	21,190	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
BIOMARIN PHARMACEUTICAL INCListing on record	Oct 1, 2024	Award	7,870	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC